enGene Holdings Inc (NASDAQ:ENGN) has a beta value of -0.65 and has seen 0.11 million shares traded in the last trading session. The company, currently valued at $300.78M, closed the last trade at $5.90 per share which meant it lost -$0.35 on the day or -5.60% during that session. The ENGN stock price is -211.86% off its 52-week high price of $18.40 and 25.08% above the 52-week low of $4.42. If we look at the company’s 10-day average daily trading volume, we find that it stood at 73190.0 shares traded. The 3-month trading volume is 154.87K shares.
The consensus among analysts is that enGene Holdings Inc (ENGN) is Buy stock at the moment, with a recommendation rating of 1.30. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.38.
enGene Holdings Inc (NASDAQ:ENGN) trade information
Sporting -5.60% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ENGN stock price touched $5.90 or saw a rise of 11.68%. Year-to-date, enGene Holdings Inc shares have moved -11.28%, while the 5-day performance has seen it change -6.35%. Over the past 30 days, the shares of enGene Holdings Inc (NASDAQ:ENGN) have changed -20.59%. Short interest in the company has seen 28939.0 shares shorted with days to cover at 0.16.
Wall Street analysts have a consensus price target for the stock at $17.5, which means that the shares’ value could jump 66.29% from current levels. The projected low price target is $17.0 while the price target rests at a high of $18.0. In that case, then, we find that the current price level is -205.08% off the targeted high while a plunge would see the stock gain -188.14% from current levels.
enGene Holdings Inc (ENGN) estimates and forecasts
The company’s shares have gained 8.26% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%. Earnings growth for 2025 is a modest -7.63% while over the next 5 years, the company’s earnings are expected to decrease by -8.86%.
ENGN Dividends
enGene Holdings Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
enGene Holdings Inc (NASDAQ:ENGN)’s Major holders
Also the top two Mutual Funds that are holding company’s shares are Franklin Strategic Series-Franklin Biotechnology Discove and Fidelity NASDAQ Composite Index Fund. As of Oct 31, 2024, the former fund manager holds about 0.81% shares in the company for having 414.26 shares of worth $2.44 million while later fund manager owns 27.52 shares of worth $0.16 million as of Nov 30, 2024, which makes it owner of about 0.05% of company’s outstanding stock.
